Dr. Zorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
# 783
Little Rock, AR 72205Phone+1 501-686-8000
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2003 - 2005
- University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 1997 - 2001
- University of Alabama School of MedicineClass of 1997
Certifications & Licensure
- AR State Medical License 2013 - 2026
- PA State Medical License 2005 - 2014
- OK State Medical License 2003 - 2006
- AL State Medical License Active through 2005
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Publications & Presentations
PubMed
- 3659 citationsIntegrated genomic characterization of endometrial carcinomaGad Getz, Stacey Gabriel, Kristian Cibulskis, Eric S. Lander, Andrey Sivachenko
Nature. 2013-05-02 - 255 citationsIdentification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Roger L. Milne, Karoline Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar
Nature Genetics. 2017-10-23 - 205 citationsMutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R. Rebbeck, Tara M. Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo
Human Mutation. 2018-05-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: